Average Co-Inventor Count = 6.38
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Stemcentrx LLC (24 from 40 patents)
2. Stemcentrx, Inc. (14 from 18 patents)
38 patents:
1. 11033634 - Light chain variable regions
2. 10934359 - Anti-BMPR1B antibodies and methods of use
3. 10533051 - Anti SEZ6 antibodies and methods of use
4. 10428156 - Anti-MFI2 antibodies and methods of use
5. 10308721 - Anti-DLL3 antibodies and drug conjugates for use in melanoma
6. 10189910 - Anti-DPEP3 antibodies and methods of use
7. 10137204 - Anti-DLL3 antibody drug conjugates for treating cancer
8. 10053511 - Anti-claudin antibodies and methods of use
9. 9993566 - SEZ6 modulators and methods of use
10. 9937268 - Anti-DLL3 antibody drug conjugates and methods of use
11. 9931421 - Methods of delivering DLL3 antibody drug conjugates
12. 9931420 - Methods of making DLL3 antibody drug conjugates
13. 9878053 - Methods of delivering DLL3 antibody drug conjugates
14. 9867887 - Anti-DLL3 antibody drug conjugates
15. 9861708 - Kits containing DLL3 antibody drug conjugates